Chemoresistance is one of the main problems in the therapy of cancer. There are a number of different molecular mechanisms through which a cancer cell acquires resistance to a specific treatment, such as alterations in drug uptake, drug metabolism and drug targets. There are several lines of evidence showing that miRNAs are involved in drug sensitivity of cancer cells in different tumor types and by different treatments. In this review, we provide an overview of the more recent and significant findings on the role of miRNAs in cancer cell drug resistance. In particular, we focus on specific miRNA mechanisms of action that in various steps lead from drug cell sensitivity to drug cell resistance. We also provide evidence on how miRNA profiling may unveil relevant predictive biomarkers for therapy outcomes.
MicroRNAs : short non-coding players in cancer chemoresistance / S. Donzelli, F. Mori, F. Biagioni, T. Bellissimo, C. Pulito, P. Muti, S. Strano, G. Blandino. - In: MOLECULAR AND CELLULAR THERAPIES. - ISSN 2052-8426. - 2:1(2014), pp. 16.1-16.12.
|Titolo:||MicroRNAs : short non-coding players in cancer chemoresistance|
MUTI, PAOLA CORNELIA MARIA [Conceptualization]
|Parole Chiave:||Chemoresistance; MicroRNA; Multiple drug resistance|
|Settore Scientifico Disciplinare:||Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica|
|Data di pubblicazione:||2014|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1186/2052-8426-2-16|
|Appare nelle tipologie:||01 - Articolo su periodico|